IgG1 B cell receptor signaling is inhibited by CD22 and promotes the development of B cells whose survival is less dependent on Igα/β

Ari Waisman(Universidade Federal de São Paulo), Klaus Rajewsky(Max Delbrück Center), Doron Melamed(Technion – Israel Institute of Technology), Manfred Kraus(Harvard University), Lars Nitschke(Friedrich-Alexander-Universität Erlangen-Nürnberg), Frank Brombacher(University of Cape Town), Claudia Lutz(Max Planck Institute of Immunobiology and Epigenetics), Sabine Claßen(Institute of Genetics), Jane Seagal(Boston Children's Hospital), Yoshiteru Sasaki(Boston Children's Hospital), Jian Song(University of Münster), Snigdha Ghosh(Friedrich-Alexander-Universität Erlangen-Nürnberg)
The Journal of Experimental Medicine
April 9, 2007
Cited by 128


Related Papers